Sagefield Capital LP Imago Bio Sciences, Inc. Transaction History

Sagefield Capital LP

  • $825 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$15.03 - $35.96 $267,534 - $640,088
17,800 New
17,800 $639,000

Others Institutions Holding IMGO

# of Institutions
2
Shares Held
19.3K
Call Options Held
0
Put Options Held
0
View Full List

About Imago BioSciences, Inc.

IMGO Quotes by TradingView
  • Ticker IMGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,741,600
  • Description
  • Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...
More about IMGO
Track This Portfolio

Track Sagefield Capital LP Portfolio

Follow Sagefield Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sagefield Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sagefield Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email